Centiva Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Centiva Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$233K	–	1026
2019 Q4	$235K	Buy	+5,000	New	+$221K	0.01%	628

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Centiva Capital's RARX Position: Q1 2020 in Review

Centiva Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 5,000 shares — an estimated $233K sold.

Centiva Capital first reported a position in RARX in Q4 2019 and held it in 1 quarter. The position peaked at $235K in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

Centiva Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Centiva Capital sold 5,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $233K.
Centiva Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
Centiva Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $235K in Q4 2019.
144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Centiva Capital's 13F filing for Q1 2020, filed 15 May 2020.